TC BioPharm (Holdings) plc Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of GBP, except per-share amounts

	Q4 FY2024 As of Dec 31, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Intangible assets
Right of use assets, net
Property, plant and equipment
Total non-current assets
Trade and other receivables
Corporation tax receivable
Cash and cash equivalents
Total current assets
Total assets
Share capital
Share premium
Accumulated deficit
Other reserves
Total equity
Deferred income
Lease liabilities and similar
Total non-current liabilities
Trade and other payables
Convertible loan
Convertible loan derivatives
Warrant derivative liabilities
Total current liabilities
Total liabilities
ASSETS
Current assets:
Cash and cash equivalents
Corporation tax receivable
Prepaid expenses and other current assets
Total current assets
Non-current assets:
Property and equipment, net
Operating lease right of use assets
Intangible assets, net
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Convertible loan
Derivative liability
Current portion of operating lease liability
Total current liabilities
Non-current operating lease liability
Total liabilities
Shareholders’ Equity:
Ordinary shares, £0.0001 par value, 2,550,807,451 (including 559,329,010 shares declared as a stock dividend on December 30, 2024 and issued on January 3, 2025) and 20,570,088 authorized, issued, and outstanding as of December 31, 2024 and 2023, respectively
Deferred shares, £0.0001 par value, 794,955 authorized, issued, and outstanding as of December 31, 2024 and 2023, respectively
Additional paid-in capital
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments